This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Fibrostein, S.l., University of Valencia. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 52 
Years Active: 2015
Title: Carmen Aguado-Velasco: Innovator in Cancer Treatment
Introduction
Carmen Aguado-Velasco is a prominent inventor based in Valencia, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents.
Latest Patents
Carmen holds a patent for "GPBP-1 inhibition and its therapeutic use." This invention provides compositions that include anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7. These compositions are aimed at treating cancer, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Carmen has worked with notable organizations, including Fibrostein, S.L. and the University of Valencia. Her work in these institutions has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Carmen has collaborated with esteemed colleagues such as Francisco Revert-Ros and Fernando Revert. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Carmen Aguado-Velasco is a trailblazer in the realm of cancer treatment, with her innovative patent and collaborative efforts paving the way for future advancements in medical therapies. Her work exemplifies the vital role of inventors in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile